Paul Alloway - Net Worth and Insider Trading
Paul Alloway Net Worth
The estimated net worth of Paul Alloway is at least $124,559 dollars as of 2024-11-05. Paul Alloway is the See Remarks of Q32 Bio Inc and owns about 2,596 shares of Q32 Bio Inc (QTTB) stock worth over $123,102. Paul Alloway is also the See Remarks of Homology Medicines Inc and owns about 1,558 shares of Homology Medicines Inc (FIXX) stock worth over $1,456. Details can be seen in Paul Alloway's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul Alloway has not made any transactions after 2024-03-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul Alloway
Paul Alloway Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul Alloway owns 1 companies in total, including Homology Medicines Inc (FIXX) .
Click here to see the complete history of Paul Alloway’s form 4 insider trades.
Insider Ownership Summary of Paul Alloway
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FIXX | Homology Medicines Inc | 2024-01-03 | See Remarks |
Paul Alloway Latest Holdings Summary
Paul Alloway currently owns a total of 2 stocks. Among these stocks, Paul Alloway owns 2,596 shares of Q32 Bio Inc (QTTB) as of March 25, 2024, with a value of $123,102 and a weighting of 98.83%. Paul Alloway also owns 1,558 shares of Homology Medicines Inc (FIXX) as of January 3, 2024, with a value of $1,456 and a weighting of 1.17%.
Latest Holdings of Paul Alloway
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| QTTB | Q32 Bio Inc | 2024-03-25 | 2,596 | 47.42 | 123,102 |
| FIXX | Homology Medicines Inc | 2024-01-03 | 1,558 | 0.93 | 1,456 |
Holding Weightings of Paul Alloway
Paul Alloway Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul Alloway has made a total of 1 transactions in Q32 Bio Inc (QTTB) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Q32 Bio Inc is the sale of 268 shares on March 25, 2024, which brought Paul Alloway around $6,488.
According to the SEC Form 4 filings, Paul Alloway has made a total of 3 transactions in Homology Medicines Inc (FIXX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Homology Medicines Inc is the sale of 404 shares on January 3, 2024, which brought Paul Alloway around $4,150.
Insider Trading History of Paul Alloway
- 1
Paul Alloway Trading Performance
Paul Alloway Ownership Network
Ownership Network List of Paul Alloway
Ownership Network Relation of Paul Alloway
Paul Alloway Owned Company Details
What does Homology Medicines Inc do?
Who are the key executives at Homology Medicines Inc?
Paul Alloway is the See Remarks of Homology Medicines Inc. Other key executives at Homology Medicines Inc include director & President & CEO Arthur Tzianabos , Chief Scientific Officer Albert Seymour , and Chief Medical Officer Julie Jordan .
Homology Medicines Inc (FIXX) Insider Trades Summary
Over the past 18 months, Paul Alloway made 1 insider transaction in Homology Medicines Inc (FIXX) with a net sale of 7,280. Other recent insider transactions involving Homology Medicines Inc (FIXX) include a net sale of 1,952 shares made by Julie Jordan , a net sale of 13,037 shares made by Arthur Tzianabos , and a net sale of 1,708 shares made by .
In summary, during the past 3 months, insiders sold 0 shares of Homology Medicines Inc (FIXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,413 shares of Homology Medicines Inc (FIXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,413 shares.
Homology Medicines Inc (FIXX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Homology Medicines Inc Insider Transactions
Paul Alloway Mailing Address
Above is the net worth, insider trading, and ownership report for Paul Alloway. You might contact Paul Alloway via mailing address: C/o Homology Medicines, Inc., 45 Wiggins Avenue, Bedford Ma 01730.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
